Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (10): 93-98    DOI:
    
Strategy of Structural Analysis for Biosimilar Monoclonal Antibody Drug
JIA Wei, CHEN Xi, ZHOU Chun-xi, SONG Lan-kun
Waters Technologies Shanghai Limited, Shanghai 100026, China
Download: HTML   PDF(778KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  The patent protection period of many monoclonal antibody drugs will expire, which market value will be over a hundred billion dollars. It is very important for developing countries to improve their medical system and upgrade industries. But, there are huge difficulties in developing biosimilar monoclonal antibody, which must use LCMS system to overcome. How to use LCMS system to get required data item for biosimilar monoclonal antibody was shown. Besides techniques, the work efficiency and law requirements for biosimilar drug production were also discussed.

Key wordsMonoclonal antibody      Biosimilar drug      LCMS      QTOF      UPLC     
Received: 29 June 2012      Published: 25 October 2012
ZTFLH:  Q819  
Cite this article:

JIA Wei, CHEN Xi, ZHOU Chun-xi, SONG Lan-kun. Strategy of Structural Analysis for Biosimilar Monoclonal Antibody Drug. China Biotechnology, 2012, 32(10): 93-98.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I10/93

[1] Hongwei Xie, Asish Chakraborty, Joomi Ahn, et al. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies. mAbs, 2010,2(4): 1-16.
[2] Martin Gilar, Ying-Qing Yu, Joomi Ahn, et al. Characterization of glycoprotein digests with hydrophilic interaction chromatography and mass spectrometry. Analytical Biochemistry. 2011, 417: 80-88.
[3] Kallol Gupta, Mukesh Kumar, Padmanabhan Balaram. Disulfide bond assignments by mass spectrometry of native natural peptides: cysteine pairing in disulfide bonded conotoxins. Anal Chem, 2010, 82:8313-8319.
[4] Hongwei Xie, Weibin Chen. Fast and automatic mapping of disulfide bonds in a monoclonal antibody using SYNAPT G2 HDMS and BiopharmaLynx 1.3. Waters Application Note, 2011, 720003939EN.
[5] Kevin Blackburn, Flaubert Mbeunkui, Srijeet K Mitra. Improving protein and proteome coverage through data-independent multiplexed peptide fragmentation. Journal of Proteome Research, 2010, 9:3621-3637.
[6] Hongwei Xie, Martin Gilar, Asish Chakraborty. Monitoring deamidation progression in an antibody tryptic digest using UPLC/MSE with BiopharmaLynx and a Xevo QTof MS System. Waters Application Note. 2009, 720003168EN.
[7] John R Engen. Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS. Anal Chem, 2009, 81:7870-7875.
[8] Huang L, Gough P C, Defelippis M R. Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines. Anal Chem, 2009, 81:567-577.
[9] Lu X, Gough P C, DeFelippis M R, et al. Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS. J Am Soc Mass Spectrom, 2010, 21:810-818.
[10] Doneanu C E, Xenopoulos A, Fadgen K, et al. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry. mAbs, 2012,4(1): 24-44.
[11] ACQUITY UPLC H-Class Bio System. Waters Application Note, 2011, 720003482EN.
[1] ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.
[2] WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. Accurate Detection of Streptococcus pneumoniae by Using Ribosomal Protein L7 / L12 as Molecular Marker[J]. China Biotechnology, 2020, 40(4): 34-41.
[3] JIANG Yi-fan,JIA Yu,Wang Long,WANG Zhi-ming. The Glycosylation Design and Control of Monoclonal Antibody by Cell Culture[J]. China Biotechnology, 2019, 39(8): 95-103.
[4] LIU Guo-fang,LIU Xiao-zhi,GAO Jian,WANG Zhi-ming. Effects of Host Cell Residual Proteins on the Quality and Their Quality Control of Monoclonal Antibody[J]. China Biotechnology, 2019, 39(10): 105-110.
[5] Jian-wei REN,Jun LI,Shang-ze LI. Human CT55 Protein Prokaryotic Expression and Its Production of Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 1-8.
[6] Kai-yun MAO,Yue-lei FAN,Heng-zhe WANG,Da-ming CHEN. Market Competition Pattern of Global PD-1/PD-L1 Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 103-115.
[7] Jing-jing SUN,Wei-wei ZHOU,Lei-ming ZHOU,Qiao-hui ZHAO,Gui-lin LI. Advance in Large-Scale Culture of Hybridoma Cells in Vitro[J]. China Biotechnology, 2018, 38(10): 82-89.
[8] Si-ming JIAO,Gong CHENG,Yu-chen ZHANG,Cui FENG,Li-shi REN,Jian-jun LI,Yu-guang DU. Expression of Chitinase from Trichoderma reesei and Analysis the Composition and Structure of its Hydrolysates[J]. China Biotechnology, 2018, 38(10): 30-37.
[9] Yi HUANG,Xiao-yu LI,Fang TIAN,Xiao-hong QIAN,Wan-tao YING. Identification and Quantitative Study on Glycosylation Chain Modification of Antibody Drugs by Mass Spectrometry[J]. China Biotechnology, 2018, 38(1): 32-41.
[10] WANG Yun-long, ZHAO Er-xia, LI Yu-lin. Expression, Purification and Identification of Thymidine Kinase 1 Recombinant Protein[J]. China Biotechnology, 2017, 37(9): 15-22.
[11] WU Meng-ling, ZHOU Jia-wang, DU Jun. Development and Application of A Double Monoclonal Antibody Sandwich ELISA for the Assay of Nodal[J]. China Biotechnology, 2017, 37(3): 51-57.
[12] LI Min, WU Ri-wei. The Market Overview of Monoclonal Antibodies in Both Domestic and Abroad[J]. China Biotechnology, 2017, 37(3): 106-114.
[13] REN Hua-jing, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian. Progression of Central Nervous System Disease Therapeutic Antibody Drug Application[J]. China Biotechnology, 2016, 36(9): 54-58.
[14] ZHANG Yin-chuan, LIU Meng-meng, ZHANG Ya-ting, GUI Fang, ZHANG Ai-hua, BI Lan, PAN Yong-bin. Construction and Screening of Recombinant Cell Line Expressing Fully-human mAbs against Human IgE[J]. China Biotechnology, 2015, 35(3): 66-74.
[15] WANG Lan, XIA Mao, GAO Kai. The Development and Quality Control of Antibody-Drug Conjugates[J]. China Biotechnology, 2014, 34(4): 85-94.